Congress Materials

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Oral Presentation
Gnant M, Dueck A, Frantal S, Martin M, Burstein H, Greil R, Fox P, Wolff A, Chan A, Winer E, Singer C, Miller K, Colleoni M, Naughton M, Rubovszky G, Bliss J, Mayer I, Steger GG, Nowecki Z, Hahn O, Wolmark N, Rugo H, Pfeiler G, Fohler H, Metzger O, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL December 8, 2021 SABCS 2021 Breast Cancer

Adjuvant palbociclib in HR+/HER2- early breast cancer: Final protocol-planned analysis results from 5,761 patients in the randomized phase III PALLAS trial

View Presentation
Poster
Tripathy D, Zhang Z, Blum J, Karuturi M, McCune S, Telivala B, Lakhanpal S, Patel K, Frank R, Lu K, Deshpande C, Wang Y, Liu Y, Bardia A December 8, 2021 SABCS 2021 Breast Cancer

Early Changes in Circulating Tumor DNA and Its Effect on Clinical Outcomes in Patients With Advanced Breast Cancer Receiving the CDK4/6 Inhibitor Palbociclib: Genotyping Results From POLARIS

View Presentation View Abstract Plain Language Summary
Poster
Isaacs C, Mahtani R, Lynce F, Sleckman B, Castrellon A, Kalmadi S, Theall KP, Huang X, Bananis E, Rugo HS December 8, 2021 SABCS 2021 Breast Cancer

Efficacy and Safety of Palbociclib Plus Endocrine Therapy in Black and Hispanic Patients With Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer (HR+/ HER2– ABC) Participating in the PALOMA Trials

View Presentation View Abstract Plain Language Summary
Poster
Brain E, Pulido M, Paillaud E, Grosjean J, Mina W, Caillet P, Tassy L, Soubeyran P, Bouteiller F, Rifi N, Vauthier JM, Falandry C, Carola E December 8, 2021 SABCS 2021 Breast Cancer

Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PalomAGE study

View Presentation View Abstract Plain Language Summary
Poster
Niyazov A, Izano MA, Johanson C, Walters S, Berry A, Arondekar B, Laird AD, Arruda LS, Kaplan H December 8, 2021 SABCS 2021 Breast Cancer

Germline BRCA1/2 Mutation Testing in Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced Breast Cancer (ABC): A Real-World Study in the Syapse Learning Health Network (LHN)

View Presentation View Abstract Plain Language Summary
Poster
Whitaker K, Parikh RC, Esterberg E, Arondekar B, Hitchens A, Arruda LS, Niyazov A, Obeid E December 8, 2021 SABCS 2021 Breast Cancer

Impact of Race on Clinical Outcomes Among Patients With Advanced Triple Negative Breast Cancer (TNBC) and Germline BRCA1/2 Mutation(s) (gBRCA1/2mut): Results From a US Real-World Study

View Presentation View Abstract Plain Language Summary
Poster
Cheang MCU, Dowsett M, Rimawi M, Johnston S, Jacobs S, Bliss J, Pogue-Geile K, Kilburn L, Zhu Z, Schuster EF, Xiao H, Swaim L, Deng S, Lu DR, Gauthier E, Tursi J, Slamon DJ, Rugo HS, Finn RS, Liu Y December 8, 2021 SABCS 2021 Breast Cancer

Impact of Using Cross-Platform Gene Expression Profiling Technologies and Computational Methods for Intrinsic Breast Cancer Subtyping in PALOMA-2 and PALLET

View Presentation View Abstract Plain Language Summary
Poster
Blum JL, DiCristo C, Gordon D, Karuturi MS, Oubre D, Jepsen E, Cuevas J, Lakhanpal S, Zhang Z, Wang Y, Tripathy D December 8, 2021 SABCS 2021 Breast Cancer

Male Patients With HR+/HER2–Advanced Breast Cancer Receiving Palbociclib in a Real-World Setting: Patient Characteristics, Treatment Patterns, and Outcomes in the POLARIS Study

View Presentation View Abstract Plain Language Summary
Poster
Denkert C, Marmé F, Martin M, Untch M, Bonnefoi H, Kim S-B, Bear H, Witkiewicz A, Im S-A, DeMichele A, Van’t Veer L, McCarthy N, Stiewe T, Gelmon KA, García-Sáenz JA, Kelly CM, Reimer T, Knudsen E, Turner N, Rojo F, Fasching PA, Teply-Szymanski J, Liu Y, Toi M, Rugo HS, Gnant M, Makris A, Felder B, Weber K, Loibl S December 8, 2021 SABCS 2021 Breast Cancer

Molecular plasticity of luminal breast cancer and response to CDK 4/6 inhibition – the biomarker program of the PENELOPE-B trial investigating post-neoadjuvant Palbociclib

View Presentation
Poster
Loirat D, Duboys de Labarre M, Essner C, Hrab I, Thery J-C, Jouannaud C, Villanueva C, Vuagnat P, Soibinet-Oudot P, Creisson A, Mailliez A, Mouysset J-L, Salabert L, Dohollou N, Fumet J-D, De La Motte Rouge T, Vauthier J-M, Decrop M, Pujol P December 8, 2021 SABCS 2021 Breast Cancer

Phase IV study evaluating effectiveness and safety of talazoparib in patients with locally advanced or metastatic HER2 negative breast cancer and a BRCA1 or BRCA2 mutation (ViTAL)

View Presentation